Search

everythinglearnresearchcommunity

for

Search:↓

Combining specific proteins and cell-derived particles may help treat hair loss.

DKK proteins could help diagnose and treat various non-cancerous diseases.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Scientists found markers called CD34 and CD200 that help identify stem cells in mouse and human hair follicles.

The treatments stopped hair regrowth in mice.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

p2y5, now called LPA6, is a receptor important for human hair growth.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Fzd2 is important for skin and hair development through various signaling ways.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

The EDA pathway plays a key role in bone development by interacting with other signaling pathways.

Computational methods help design drugs targeting prostate cancer proteins.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

PDGF and its receptors are crucial for stem cell growth and function.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Blocking cell death in certain stem cells can improve wound healing and tissue regeneration.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Cells that move well may improve hair loss treatments by entering hair follicles.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.